Pasar al contenido principal

TERAPIAS DIRIGIDAS CONTRA LA INESTABILIDAD CROMOSOMICA EN CANCER

PID2019-111356RA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma

  • Calsina, Bruna
  • Piñeiro-Yáñez, Elena
  • Martínez-Montes, Ángel M
  • Caleiras, Eduardo
  • Fernández-Sanromán, Ángel
  • Monteagudo, María
  • Torres-Pérez, Rafael
  • Fustero-Torre, Coral
  • Pulgarín-Alfaro, Marta
  • Gil, Eduardo
  • Letón, Rocío
  • Jiménez, Scherezade
  • García-Martín, Santiago
  • Martin, Maria Carmen
  • Roldán-Romero, Juan M.
  • Lanillos, Javier
  • Mellid, Sara
  • Santos, María
  • Díaz-Talavera, Alberto
  • Rubio, Ángeles
  • González, Patricia
  • Hernando, Barbara
  • Bechmann, Nicole
  • Dona, Margo
  • Calatayud, María
  • Guadalix, Sonsoles
  • Álvarez-Escolá, Cristina
  • Regojo, Rita M
  • Aller, Javier
  • Del Olmo-Garcia, Maria Isabel
  • López-Fernández, Adrià
  • Fliedner, Stephanie M J
  • Rapizzi, Elena
  • Fassnacht, Martin
  • Beuschlein, Felix
  • Quinkler, Marcus
  • Toledo, Rodrigo A
  • Mannelli, Massimo
  • Timmers, Henri J
  • Eisenhofer, Graeme
  • Rodríguez-Perales, Sandra
  • Domínguez, Orlando
  • Macintyre, Geoffrey
  • Currás-Freixes, Maria
  • Rodríguez-Antona, Cristina
  • Cascón, Alberto
  • Leandro-García, Luis Javier
  • Montero-Conde, Cristina
  • Roncador, Giovanna
  • García-García, Juan Fernando
  • Pacak, Karel
  • Al-Shahrour, Fátima
  • Robledo, Mercedes
The mechanisms triggering metastasis in pheochromocytoma/paraganglioma are unknown, hindering therapeutic options for patients with metastatic tumors (mPPGL). Herein we show by genomic profiling of a large cohort of mPPGLs that high mutational load, microsatellite instability and somatic copy-number alteration burden are associated with ATRX/TERT alterations and are suitable prognostic markers. Transcriptomic analysis defines the signaling networks involved in the acquisition of metastatic competence and establishes a gene signature related to mPPGLs, highlighting CDK1 as an additional mPPGL marker. Immunogenomics accompanied by immunohistochemistry identifies a heterogeneous ecosystem at the tumor microenvironment level, linked to the genomic subtype and tumor behavior. Specifically, we define a general immunosuppressive microenvironment in mPPGLs, the exception being PD-L1 expressing MAML3-related tumors. Our study reveals canonical markers for risk of metastasis, and suggests the usefulness of including immune parameters in clinical management for PPGL prognostication and identification of patients who might benefit from immunotherapy., This work was supported by Project PI17/01796 and PI20/01169 to M.R. [Instituto de Salud Carlos III (ISCIII), Acción Estratégica en Salud, cofi- nanciado a través del Fondo Europeo de Desarrollo Regional (FEDER)], Paradifference Foundation [no grant number applicable to M.R.], Phei- pas Association [no grant number applicable to M.R.], the Clinical Research Priority Program of the University of Zurich for the CRPP HYRENE to F.B., the Deutsche Forschungsgemeinschaft (DFG) within the CRC/Transregio 205/1 (Project No. 314061271-TRR205 to to F.B., M.F., N.B., and G.E.) and the Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Science and Innovation (Project No. PID2019-111356RA-I00 to G.M.). B.C. was supported by the Rafael del Pino Foundation (Becas de Excelencia Rafael del Pino 2017). A.M.M.-M. was supported by CAM (S2017/BMD-3724; TIRONET2-CM). A.F.-S. and J.L. received the support of a fellowship from La Caixa Foundation (ID 100010434; LCF/BQ/DR21/ 11880009 and LCF/BQ/DR19/11740015, respectively). M.M., S.M., and M.S. were supported by the Spanish Ministry of Science, Innovation and Universities “Formación del Profesorado Universitario— FPU” fellowship with ID number FPU18/00064, FPU19/04940 and FPU16/05527. A.D.-T. is supported by the Centro de Investigacion Biomédica en Red de Enfermedades Raras (CIBERER). L.J.L.-G. was supported both by the Banco Santander Foundation and La Caixa Postdoctoral Junior Leader Fellowship (LCF/BQ/PI20/11760011). C.M.-C. was supported by a grant from the AECC Foundation (AIO15152858 MONT)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

scAbsolute: measuring single-cell ploidy and replication status

  • Schneider, Michael P.
  • Cullen, Amy E.
  • Pangonyte, Justina
  • Skelton, Jason
  • Major, Harvey
  • Van Oudenhove, Elke
  • García, María J.
  • Chaves Urbano, Blas
  • Piskorz, Anna M.
  • Brenton, James D.
  • Macintyre, Geoff
  • Markowetz, Florian
Cancer cells often exhibit DNA copy number aberrations and can vary widely in their ploidy. Correct estimation of the ploidy of single-cell genomes is paramount for downstream analysis. Based only on single-cell DNA sequencing information, scAbsolute achieves accurate and unbiased measurement of single-cell ploidy and replication status, including whole-genome duplications. We demonstrate scAbsolute's capabilities using experimental cell multiplets, a FUCCI cell cycle expression system, and a benchmark against state-of-the-art methods. scAbsolute provides a robust foundation for single-cell DNA sequencing analysis across different technologies and has the potential to enable improvements in a number of downstream analyses., We would like to acknowledge the support of The University of Cambridge and Cancer Research UK (C14303/A17197 and A19274). The research was supported by UK Research and Innovation (EP/X028054/1). MPS was supported by a Marie-Sklodowska-Curie PhD Fellowship (766030-CONTRA-H2020-MSCA-ITN-2017) and an Enrichment scheme at The Alan Turing Institute (2021/2022). MJG, BCU, and GM are hosted by the Centro Nacional de Investigaciones Oncológicas (CNIO), which is supported by the Instituto de Salud Carlos III and recognized as a 'Severo Ochoa' Centre of Excellence (ref. CEX2019-000891-S) by the Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033). This work was supported by grants to GM by the Spanish Ministry of Science and Innovation (PID2019-111356RA-I00 funded by MCIN/AEI /10.13039/501100011033 and PID2022-137042OB-I00 funded by MCIN/AEI /10.13039/501100011033 and by the European Union, ERDF "A way of making Europe"), With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000891-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CNpare: matching DNA copy number profiles

  • Chaves-Urbano, Blas
  • Hernando, Barbara
  • García, María J.
  • Macintyre, Geoff
Selecting the optimal cancer cell line for an experiment can be challenging given the diversity of lines available. Here, we present CNpare, which identifies similar cell line models based on genome-wide DNA copy number., All authors are hosted by the Centro Nacional de Investigaciones Oncológicas (CNIO), which was supported by the Instituto de Salud Carlos III and recognized as a ‘Severo Ochoa’ Centre of Excellence (ref. CEX2019-000891-S) by the Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033). Authors were also supported by a Spanish Ministry of Science and Innovation grant PID2019-111356RA-I00 (MCIN/AEI/10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000891-S)., Peer reviewed